Salivary biomarkers in oral squamous cell carcinoma

키워드

참고문헌 (70)

1. Mishra A, "Cancer biomarkers: are we ready for the prime time?", Cancers (Basel), 2, pp.190~208 (2010)[DOI]
2. Shield KD, "The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012", CA Cancer J Clin, 67, pp.51~64 (2017)[DOI]
3. Conway DI, "The changing epidemiology of oral cancer : definitions, trends, and risk factors", Br Dent J, 225, pp.867~873 (2018)[DOI]
4. Patel RS, "Prognostic factors in the surgical treatment of patients with oral carcinoma", ANZ J Surg, 79, pp.19~22 (2009)[DOI]
5. Gupta N, "Changing Trends in oral cancer-a global scenario", Nepal J Epidemiol, 6, pp.613~619 (2016)[DOI]
6. Johnson NW, "Squamous cell carcinoma and precursor lesions of the oral cavity : epidemiology and aetiology", Periodontol 2000, 57, pp.19~37 (2011)[DOI]
7. Ilbawi AM, "Cancer in global health : how do prevention and early detection strategies relate", Sci Transl Med, 7, pp.278~ (2015)[DOI]
8. Lousada-Fernandez F, "Liquid biopsy in oral cancer", Int J Mol Sci, 19, pp.1704~ (2018)[DOI]
9. Cheng YS, "A review of research on salivary biomarkers for oral cancer detection", Clin Transl Med, 3, pp.3~ (2014)[DOI]
10. Thomadaki K, "Whole-saliva proteolysis and its impact on salivary diagnostics", J Dent Res, 90, pp.1325~1330 (2011)[DOI]
11. Arglebe C, "Biochemistry of human saliva", Adv Otorhinolaryngol, 26, pp.97~234 (1981)[DOI]
12. Kaczor-Urbanowicz KE, "Saliva diagnostics - current views and directions", Exp Biol Med (Maywood), 245, pp.459~472 (2017)[DOI]
13. Hu S, "Human saliva proteome analysis and disease biomarker discovery", Expert Rev Proteomics, 4, pp.531~538 (2007)[DOI]
14. Wong DT, "Salivaomics", J Am Dent Assoc, 143(10 Suppl), pp.19S~24S (2012)[DOI]
15. Tachibana M, "Expression and prognostic significance of EFNB2and EphB4 genes in patients with oesophageal squamous cell carcinoma", Dig Liver Dis, 39, pp.725~732 (2007)[DOI]
16. Shpitzer T, "Salivary analysis of oral cancer biomarkers", Br J Cancer, 101, pp.1194~1198 (2009)[DOI]
17. Rajkumar K, "Estimation of serological and salivary biomarkers in patients vith oral squamous cell carcinoma, premalignant lesions & conditions", SRM J Res Dent Sci, 1, pp.14~19 (2010)
18. St John MA, "Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma", Arch Otolaryngol Head Neck Surg, 130, pp.929~935 (2004)[DOI]
19. Arellano-Garcia ME, "Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva", Oral Dis, 14, pp.705~712 (2008)[DOI]
20. Khurshid Z, "Role of salivary biomarkers in oral cancer detection", Adv Clin Chem, 86, pp.23~70 (2018)[DOI]
21. de Jong EP, "Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions", PLoS One, 5, pp.e11148~ (2010)[DOI]
22. Wang Q, "Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma", Clin Chim Acta, 427, pp.79~85 (2014)[DOI]
23. Camisasca DR, "A proteomic approach to compare saliva from individuals with and without oral leukoplakia", J Proteomics, 151, pp.43~52 (2017)[DOI]
24. Flores IL, "Low expression of angiotensinogen and dipeptidyl peptidase 1in saliva of patients with proliferative verrucous leukoplakia", World J Clin Cases, 4, pp.356~363 (2016)[DOI]
25. Hu S, "Salivary proteomics for oral cancer biomarker discovery", Clin Cancer Res, 14, pp.6246~6252 (2008)[DOI]
26. Almadori G, "Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma", Head Neck, 29, pp.648~654 (2007)[DOI]
27. Jou YJ, "Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer", Anal Chim Acta, 681, pp.41~48 (2010)[DOI]
28. Katakura A, "Comparison of salivary cytokine levels in oral cancer patients and healthy subjects", Bull Tokyo Dent Coll, 48, pp.199~203 (2007)[DOI]
29. Duffy SA, "Interleukin-6 predicts recurrence and survival among head and neck cancer patients", Cancer, 113, pp.750~757 (2008)[DOI]
30. Zhong LP, "Detection of telomerase activity in saliva from oral squamous cell carcinoma patients", Int J Oral Maxillofac Surg, 34, pp.566~570 (2005)[DOI]
31. Krishna Prasad RB, "An insight into salivary markers in oral cancer", Dent Res J(Isfahan), 10, pp.287~295 (2013)
32. Franzmann EJ, "Soluble CD44 is a potential marker for the early detection of head and neck cancer", Cancer Epidemiol Biomarkers Prev, 16, pp.1348~1355 (2007)[DOI]
33. Kumar M, "Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients", J Transl Med, 13, pp.8~ (2015)[DOI]
34. Righini CA, "Tumor-specific methylation in saliva : a promising biomarker for early detection of head and neck cancer recurrence", Clin Cancer Res, 13, pp.1179~1185 (2007)[DOI]
35. Reddy I, "Amino acid profile of saliva from patients with oral squamous cell carcinoma using high performance liquid chromatography", J Oral Sci, 54, pp.279~283 (2012)[DOI]
36. Al Kawas S, "Potential uses of human salivary protein and peptide analysis in the diagnosis of disease", Arch Oral Biol, 57, pp.1~9 (2012)[DOI]
37. Li Y, "Salivary transcriptome diagnostics for oral cancer detection", Clin Cancer Res, 10, pp.8442~8450 (2004)[DOI]
38. Elashoff D, "Prevalidation of salivary biomarkers for oral cancer detection", Cancer Epidemiol Biomarkers Prev, 2, pp.664~672 (2012)[DOI]
39. Tang H, "Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis", Mol Med Rep, 7, pp.761~766 (2013)[DOI]
40. Liu CJ, "Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma", Head Neck, 34, pp.219~224 (2012)[DOI]
41. Park NJ, "Salivary microRNA : discovery, characterization, and clinical utility for oral cancer detection", Clin Cancer Res, 15, pp.5473~5477 (2009)[DOI]
42. Wei J, "Salivary metabolite signatures of oral cancer and leukoplakia", Int J Cancer, 129, pp.2207~2217 (2011)[DOI]
43. Sugimoto M, "Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles", Metabolomics, 6, pp.78~95 (2010)[DOI]
44. Ishikawa S, "Identification of salivary metabolomic biomarkers for oral cancer screening", Sci Rep, 6, pp.31520~ (2016)[DOI]
45. Feng Y, "Salivary protease spectrum biomarkers of oral cancer", Int J Oral Sci, 11, pp.7~ (2019)[DOI]
46. Peng M, "Non-blood circulating tumor DNA detection in cancer", Oncotarget, 8, pp.69162~69173 (2017)[DOI]
47. Zhang CZ, "Saliva in the diagnosis of diseases", Int J Oral Sci, 8, pp.133~137 (2016)[DOI]
48. Gröbe A, "Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity", Clin Cancer Res, 20, pp.425~433 (2014)[DOI]
49. Bhattarai KR, "Compliance with saliva collection protocol in healthy volunteers : strategies for managing risk and errors", Int J Med Sci, 15, pp.823~831 (2018)[DOI]
50. Golatowski C, "Comparative evaluation of saliva collection methods for proteome analysis", Clin Chim Acta, 419, pp.42~46 (2013)[DOI]
51. Navazesh M, "Methods for collecting saliva", Ann N Y Acad Sci, 694, pp.72~77 (1993)[DOI]
52. Yoshizawa JM, "Salivary biomarkers : toward future clinical and diagnostic utilities", Clin Microbiol Rev, 26, pp.781~791 (2013)[DOI]
53. Nassar M, "Age-related changes in salivary biomarkers", J Dent Sci, 9, pp.85~90 (2014)[DOI]
54. Cabras T, "Age-dependent modifications of the human salivary secretory protein complex", J Proteome Res, 8, pp.4126~4134 (2009)[DOI]
55. Fenoll-Palomares C, "Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers", Rev Esp Enferm Dig, 96, pp.773~783 (2004)[DOI]
56. Chiappin S, "Saliva specimen : a new laboratory tool for diagnostic and basic investigation", Clin Chim Acta, 383, pp.30~40 (2007)[DOI]
57. Henson BS, "Collection, storage, and processing of saliva samples for downstream molecular applications", Methods Mol Biol, 666, pp.21~30 (2010)[DOI]
58. Shirtcliff EA, "Use of salivary biomarkers in biobehavioral research : cotton-based sample collection methods can interfere with salivary immunoassay results", Psychoneuroendocrinology, 26, pp.165~173 (2001)[DOI]
59. Williamson S, "Comparison of biomarkers in blood and saliva in healthy adults", Nurs Res Pract, 2012, pp.246178~ (2012)[DOI]
60. Ngamchuea K, "Can saliva testing replace blood measurements for health monitoring? Insights from a correlation study of salivary and whole blood glutathione in humans", Analyst, 14, pp.4707~4712 (2016)[DOI]
61. Sharma M, "Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer", J Cancer Res Ther, 16, pp.546~550 (2020)[DOI]
62. Singh P, "Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation", Indian J Dent Res, 28, pp.162~168 (2017)[DOI]
63. Aziz NZ, "Evaluation of magnesium levels in blood and saliva of oral squamous cell carcinoma and potentially malignant disorders by xylidyl blue method", J Oral Maxillofac Pathol, 22, pp.147~ (2018)[DOI]
64. Metgud R, "Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy", Biotech Histochem, 89, pp.8~13 (2014)[DOI]
65. Ai J, "Saliva ontology : an ontology-based framework for a Salivaomics knowledge base", BMC Bioinformatics, 11, pp.302~ (2010)[DOI]
66. Wu CC, "Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma", Proteomics, 15, pp.3394~3404 (2015)[DOI]
67. Flannery CR, "MMPs and ADAMTSs : functional studies", Front Biosci, 11, pp.544~569 (2006)[DOI]
68. Kim JM, "Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid", Int J Oral Sci, 6, pp.150~153 (2014)[DOI]
69. Edwards DR, "The ADAM metalloproteinases", Mol Aspects Med, 29, pp.258~289 (2008)[DOI]
70. Chu HW, "Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches", Mol Cell Proteomics, 18, pp.1796~1806 (2019)[DOI]

관련 논문AI추천